Fig. 2From: Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patientsKaplan-Meier estimates of overall survival of the patients treated with GD as adjuvant, first-line, second-line, and third-or-greater line settingBack to article page